Finally, in a human IL-32γ-expressing transgenic mouse model, when mice expressed human IL-32γ, streptozotocin-induced diabetes was accelerated (58), highlighting IL-32 as an important biomarker for T1D progression. This evidence concerns the gene IL32 and diabetes mellitus.